John H. Rex
Chief Tech/Sci/R&D Officer at F2G Ltd.
Profile
John H.
Rex is currently the Chief Medical Officer & Director at F2G Ltd.
He is also an Operating Partner at Advent Venture Partners LLP.
Previously, he served as the Vice Chairman at CLSI, Inc. and as the Head-Infection & Global Medicines Development at AstraZeneca GmbH from 2003 to 2016.
Dr. Rex completed his undergraduate degree at Rice University and obtained a doctorate from Baylor College of Medicine.
John H. Rex active positions
Companies | Position | Start |
---|---|---|
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Chief Tech/Sci/R&D Officer | 02/11/2016 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Consultant / Advisor | 01/11/2015 |
Former positions of John H. Rex
Companies | Position | End |
---|---|---|
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Corporate Officer/Principal | 01/10/2016 |
CLSI, Inc.
CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992. | Director/Board Member | - |
Training of John H. Rex
Rice University | Undergraduate Degree |
Baylor College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Health Technology |
CLSI, Inc.
CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992. | Technology Services |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
- Stock Market
- Insiders
- John H. Rex